KFA
PCRX icon

Kelleher Financial Advisors’s Pacira BioSciences PCRX Stock Holding History

Kelleher Financial Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93K Buy
+76
New +$1.8K ﹤0.01% 759

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kelleher Financial Advisors's PCRX Position: Q2 2026 in Review

Kelleher Financial Advisors opened a new position in Pacira BioSciences (PCRX) in Q2 2026: 76 shares worth $1.93K. The stake represents ﹤0.01% of the portfolio and ranks #759 among its holdings.

252 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Kelleher Financial Advisors held 76 shares of Pacira BioSciences worth $1.93K as of Q2 2026.
  • Pacira BioSciences was a new Kelleher Financial Advisors position in Q2 2026.
  • Pacira BioSciences made up ﹤0.01% of Kelleher Financial Advisors's portfolio in Q2 2026, its #759 holding.
  • 252 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Kelleher Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.